BioRestorative Therapies Stock Forecast for 2023 - 2025 - 2030
Updated on 04/30/2024
BioRestorative Therapies Stock Forecast and Price Target
The average target price for BioRestorative Therapies's stock set by renowned analysts in recent months is $10.50, representing a potential upside of approximately 639.44% from its last closing price if met by 2025. This estimation is based on a high estimate of $15.00 and a low estimate of $6.00. If interested in BRTX stock, you may also want to consider its competitors.
639.44% Upside
BioRestorative Therapies Fair Value Forecast for 2023 - 2025 - 2030
In the last year, BioRestorative Therapies's Price has grown, rising from $0.00 to $0.00 – a growth of 100.00%. In the next year, analysts believe that Fair Value will reach $1.53 – an increase of 100.00%. For the next seven years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BAX Stock Forecast | Baxter International Inc | Outperform |
17
|
$40.37 | Buy/Sell | $44.86 | 11.47% |
| VCEL Stock Forecast | Vericel | Buy |
8
|
$45.87 | Buy/Sell | $42.58 | 19.90% |
| GERN Stock Forecast | Geron | Buy |
6
|
$3.93 | Buy/Sell | $4.83 | 27.23% |
| LCTX Stock Forecast | Lineage Cell Therapeutics | Outperform |
11
|
$1.09 | Buy/Sell | $5.40 | 358.72% |
| MSB Stock Forecast | Mesoblast | Buy |
9
|
$0.99 | Buy/Sell | $0.69 | 11.11% |
BioRestorative Therapies Revenue Forecast for 2023 - 2025 - 2030
In the last three years, BioRestorative Therapies's Revenue has grown, rising from $80.00k to $150.00k – a growth of 87.50%. The next year, 2 experts forecast that BioRestorative Therapies's Revenue will decrease by 60.00%, reaching $60.00k. For the next seven years, the forecast is for Revenue to grow by 309346.67%.
.jpg)
BioRestorative Therapies EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, BioRestorative Therapies's EBITDA has grown by 472.62%, rising from $-2.63M to $-15.06M. According to 0 prominent analysts, BioRestorative Therapies's EBITDA will fall by 8.57% in the next year, reaching $-13.77M. Over the next seven years, experts believe that BioRestorative Therapies's EBITDA will grow at a rate of 12.40%.
BioRestorative Therapies EBIT Forecast for 2023 - 2025 - 2030
In the last three years, BioRestorative Therapies's EBIT has grown, moving from $-2.75M to $-15.22M – an increase of 453.45%. In the next year, analysts predict that EBIT will jump to $-22.53M – up 48.03% from the current level. In 2030, professionals predict that BioRestorative Therapies's EBIT will decrease by 2232.19%, to $324.52M.
BioRestorative Therapies EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last year, BioRestorative Therapies's EPS has grown, rising from $-3.42 to $0.00 – a growth of 100.00%. In the next year, analysts believe that EPS will reach $-2.46 – an increase of 100.00%. For the next seven years, the forecast is for EPS to grow by 100.00%.
Site Navigation
.jpg)